- Organizations: ImprimisRx
Business
Leadership update: ImprimisRx gets new CEO, BioTissue forms MAB
Leadership changes are underway in the eyecare space—and we’ve got the latest.Products
Harrow launches next-gen atropine formulations
Patent-pending, compounded formulation is available in three concentrations.Products